Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Type of information:
other: Read across from a member of the Hydrotropes category
Adequacy of study:
weight of evidence
Study period:
July 20-August 6, 1987
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Protocols and results reviewed and accepted by the National Toxicology Program's Board of Scientific Counselor's Technical Reports Review Subcommittee, USA National Institutes of Health. The study was used as dose finding study for a carcinogenicity study.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
EPA OPP 82-2 (Repeated Dose Dermal Toxicity -21/28 Days)
Deviations:
yes
Remarks:
17 day exposure
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Reference substance name:
Sodium (xylenes and 4-ethylbenzene) sulfonates
EC Number:
701-037-1
Molecular formula:
-
IUPAC Name:
Sodium (xylenes and 4-ethylbenzene) sulfonates

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Taconic Farms, Germantown, NY
- Age at study initiation: 5 weeks
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: 1 animal per cage; polycarbonate cage on stainless steel racks with heat-treated hardwood chips and spun-bonded polyester filters; changed once per week
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 12 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.5 to 25.6
- Humidity (%): 51 to 68
- Air changes (per hr): 10 minimum
- Photoperiod (hrs dark / hrs light): 12 / 12IN
- LIFE DATES: From: July 20 To: August 6, 1987

Administration / exposure

Type of coverage:
not specified
Vehicle:
unchanged (no vehicle)
Details on exposure:
TEST SITE
- Area of exposure: clipped interscapular skin
- % coverage: no data
- Type of wrap if used: no data
- Time intervals for shavings or clipplings: once

REMOVAL OF TEST SUBSTANCE
- Washing (if done): not washed

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 300 microliters applied five days per week
- Concentration (if solution): 0, 5, 15, 44, 133 and 400 mg/mL delivered average daily doses of approximately 10, 30, 90, 260 and 800 mg/kg bw for males and 13, 40, 120, 330, and 1,030 mg/kg to females.
- Constant volume or concentration used: yes

VEHICLE
- Justification for use and choice of vehicle (if other than water): distilled water

USE OF RESTRAINERS FOR PREVENTING INGESTION: no data
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Doses analyzed by HPLC at the start of the 17 day period
Duration of treatment / exposure:
17 days
Frequency of treatment:
5 days per week
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day
Remarks:
Control for males and females
Dose / conc.:
10 mg/kg bw/day
Remarks:
Based on active ingredient, males
Dose / conc.:
30 mg/kg bw/day
Remarks:
Based on active ingredient, males
Dose / conc.:
90 mg/kg bw/day
Remarks:
Based on active ingredient, males
Dose / conc.:
260 mg/kg bw/day
Remarks:
Based on active ingredient, males
Dose / conc.:
800 mg/kg bw/day
Remarks:
Based on active ingredient, males
Dose / conc.:
13 mg/kg bw/day
Remarks:
Based on active ingredient, females
Dose / conc.:
40 mg/kg bw/day
Remarks:
Based on active ingredient, females
Dose / conc.:
120 mg/kg bw/day
Remarks:
Based on active ingredient, females
Dose / conc.:
330 mg/kg bw/day
Remarks:
Based on active ingredient, females
Dose / conc.:
1 030 mg/kg bw/day
Remarks:
Based on active ingredient, females
No. of animals per sex per dose:
5
Control animals:
yes, concurrent no treatment
Details on study design:
Dose selection rationale: wide range for screening purposes
Rationale for animal assignment: random
Positive control:
no data

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: No
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: twice daily
DERMAL IRRITATION (if dermal study): Yes
- Time schedule for examinations: twice daily

BODY WEIGHT: Yes
- Time schedule for examinations: days 1, 8 and 17

FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION: No

OPHTHALMOSCOPIC EXAMINATION: No

HAEMATOLOGY: No

CLINICAL CHEMISTRY: No

URINALYSIS: No

NEUROBEHAVIOURAL EXAMINATION: No

Sacrifice and pathology:
GROSS PATHOLOGY: Yes, A necropsy was performed on all animals. The heart, right kidney, liver, lungs, right testis, and thymus were weighed.
HISTOPATHOLOGY: Yes, Histopathologic examination was restricted to skin from the site of application, skin from an untreated site, and gross lesions.

Statistics:
Kaplan-Meier method

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Description (incidence and severity):
Only tan or brown discoloration of the skin and crusty white deposits at the application site.
In males and females, the few skin lesions observed grossly and microscopically were generally attributed to repeated clipping and were not considered related to chemical administration.
Dermal irritation:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
not examined
Other effects:
not specified
Details on results:
CLINICAL SIGNS: only tan or brown discoloration of the skin and crusty white deposits at the application site.
In males and females, the few skin lesions observed grossly and microscopically were generally attributed to repeated clipping and were not considered related to chemical administration.
MORTALITY - no mortality
BODY WEIGHT AND WEIGHT GAIN - no treatment effects
ORGAN WEIGHTS - increase in liver weights relative to body weight in males and females at two highest doses; considered not to be of toxicological relevance.
GROSS PATHOLOGY - no treatment related effects
HISTOPATHOLOGY:
NON-NEOPLASTIC - no treatment related effects

Effect levels

open allclose all
Key result
Dose descriptor:
NOAEL
Effect level:
>= 1 030 mg/kg bw/day (actual dose received)
Based on:
act. ingr.
Sex:
female
Basis for effect level:
body weight and weight gain
clinical signs
food consumption and compound intake
gross pathology
mortality
organ weights and organ / body weight ratios
Key result
Dose descriptor:
NOAEL
Effect level:
>= 800 mg/kg bw/day (actual dose received)
Based on:
act. ingr.
Sex:
male
Basis for effect level:
body weight and weight gain
clinical signs
gross pathology
mortality
organ weights and organ / body weight ratios

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

See attached tables for results details.

Applicant's summary and conclusion

Conclusions:
NOAEL > 1030 mg active ingredient/kg bw female
NOAEL > 800 mg active ingredient/kg bw male
Executive summary:

The repeated dermal toxicity of Sodium (xylenes and 4-ethylbenzene) sulfonates was assessed following official guideline EPA OPP 82-2 (Repeated dose dermal toxicity -21/28 days). There was a deviation due to the reduced administration period which was of 17 days. The test was perfomed on rats and the results showed no mortality, clinical signs only revelaed tan or brown discoloration of the skin and crusty white deposits at the application site. In males and females, the few skin lesions observed grossly and microscopically were generally attributed to repeated clipping and were not considered related to chemical administration.